Company logo

NRIX - Nurix Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
San Francisco, United States
Type: Equity

NRIX price evolution
NRIX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 28 Mar 2023
Current assets
Cash $55.53 $43.2 $59.86 $34.47
Short term investments $233.28 $216.55 $222.22 $243.57
Net receivables $2
Inventory
Total current assets $295.5 $267.95 $290.01 $288.33
Long term investments $7.42 $9.88 $27.46 $48.45
Property, plant & equipment $47.95 $25.61 $28.44 $28.63
Goodwill & intangible assets
Total noncurrent assets $60.09 $40.25 $60.61 $81.83
Total investments $240.7 $226.43 $249.68 $292.02
Total assets $355.6 $308.19 $350.62 $370.15
Current liabilities
Accounts payable $6.4 $2.19 $4.53 $5.63
Deferred revenue $93.12 $42.28 $58.75 $64.42
Short long term debt $7.49 $5.36 $5.58 $5.56
Total current liabilities $86.96 $61.49 $72.26 $64.88
Long term debt $23.13 $2.64 $3.76 $5.11
Total noncurrent liabilities $68.15 $12.88 $18.44 $31.22
Total debt $30.61 $8 $9.34 $10.66
Total liabilities $155.1 $74.38 $90.7 $96.1
Shareholders' equity
Retained earnings -$545.2 -$503.24 -$466.26 -$441.99
Other shareholder equity -$0.66 -$1.23 -$1.9 -$3.25
Total shareholder equity $200.49 $233.82 $259.92 $274.05
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $55.53 $65.38 $80.79 $119.53
Short term investments $233.28 $244.67 $215.21 $161.79
Net receivables $6 $3.85
Inventory
Total current assets $295.5 $318.45 $311.12 $298.43
Long term investments $7.42 $63.88 $137.19 $90.89
Property, plant & equipment $47.95 $29.51 $25.34 $6.67
Goodwill & intangible assets
Total noncurrent assets $60.09 $98.31 $165.65 $97.91
Total investments $240.7 $308.55 $352.4 $252.68
Total assets $355.6 $416.76 $476.77 $396.34
Current liabilities
Accounts payable $6.4 $5.06 $6.65 $3.41
Deferred revenue $93.12 $73.61 $100.23 $93.48
Short long term debt $7.49 $5.53 $3.85
Total current liabilities $86.96 $70.66 $66.26 $44.54
Long term debt $23.13 $6.43 $9.19
Total noncurrent liabilities $68.15 $42.41 $68.21 $61.53
Total debt $30.61 $11.96 $13.04
Total liabilities $155.1 $113.06 $134.47 $106.07
Shareholders' equity
Retained earnings -$545.2 -$401.25 -$220.89 -$103.7
Other shareholder equity -$0.66 -$4.32 -$0.61 $0.09
Total shareholder equity $200.49 $303.7 $342.3 $290.27
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $15.16 $18.47 $30.68 $12.69
Cost of revenue
Gross Profit $15.16 $18.47 $30.68 $12.69
Operating activities
Research & development $49.71 $47.86 $45.76 $45.82
Selling, general & administrative $10.78 $10.62 $11.68 $9.82
Total operating expenses $60.49 $58.48 $57.44 $55.64
Operating income -$45.33 -$40.01 -$26.77 -$42.95
Income from continuing operations
EBIT -$41.96 -$36.98 -$24.28 -$40.73
Income tax expense
Interest expense
Net income
Net income -$41.96 -$36.98 -$24.28 -$40.73
Income (for common shares) -$41.96 -$36.98 -$24.28 -$40.73
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $76.99 $38.63 $29.75 $17.82
Cost of revenue
Gross Profit $76.99 $38.63 $29.75 $17.82
Operating activities
Research & development $189.15 $184.5 $116.43 $66.49
Selling, general & administrative $42.9 $38 $31.2 $16.31
Total operating expenses $232.05 $222.49 $147.64 $82.8
Operating income -$155.06 -$183.87 -$117.89 -$64.98
Income from continuing operations
EBIT -$143.95 -$180.36 -$117.06 -$63.78
Income tax expense $0.13 -$20.54
Interest expense
Net income
Net income -$143.95 -$180.36 -$117.19 -$43.24
Income (for common shares) -$143.95 -$180.36 -$117.19 -$43.24
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$41.96 -$36.98 -$24.28 -$40.73
Operating activities
Depreciation $3.76 $3.38 $3.33 $3.18
Business acquisitions & disposals
Stock-based compensation $8.02 $8.45 $8.72 $8.48
Total cash flows from operations $26.69 -$41.13 -$18.47 -$48.45
Investing activities
Capital expenditures -$2.58 -$2.46 -$1.08 -$2.28
Investments -$11.79 $25.23 $44.91 $18.34
Total cash flows from investing -$14.37 $22.77 $43.83 $16.07
Financing activities
Dividends paid
Sale and purchase of stock $0.01 $1.7 $0.03 $1.48
Net borrowings
Total cash flows from financing $0.01 $1.7 $0.03 $1.48
Effect of exchange rate
Change in cash and equivalents $12.32 -$16.65 $25.39 -$30.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$143.95 -$180.36 -$117.19 -$43.24
Operating activities
Depreciation $13.65 $10.81 $6.08 $2.18
Business acquisitions & disposals
Stock-based compensation $33.67 $28.13 $15.8 $4.3
Total cash flows from operations -$81.36 -$159.81 -$84.36 -$0.08
Investing activities
Capital expenditures -$8.4 -$12.24 -$5.66 -$4.55
Investments $76.7 $39.44 -$102.59 -$249.85
Total cash flows from investing $68.3 $27.2 -$108.25 -$254.4
Financing activities
Dividends paid
Sale and purchase of stock $3.22 $117.19 $153.88 $219.11
Net borrowings
Total cash flows from financing $3.22 $117.19 $153.88 $339.02
Effect of exchange rate
Change in cash and equivalents -$9.85 -$15.42 -$38.73 $84.54
Fundamentals
Market cap $716.16M
Enterprise value $691.25M
Shares outstanding 48.72M
Revenue $76.99M
EBITDA -$130.29M
EBIT -$143.95M
Net Income -$143.95M
Revenue Q/Q 123.49%
Revenue Y/Y 99.31%
P/E ratio -4.98
EV/Sales 8.98
EV/EBITDA -5.31
EV/EBIT -4.80
P/S ratio 9.30
P/B ratio 3.56
Book/Share 4.13
Cash/Share 1.14
EPS -$2.95
ROA -41.59%
ROE -59.47%
Debt/Equity 0.77
Net debt/EBITDA -0.76
Current ratio 3.40
Quick ratio 3.40